Variant report
Variant | esv3442964 |
---|---|
Chromosome Location | chr4:3721240-3721705 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:3717339..3719373-chr4:3721279..3722918,2 | MCF-7 | breast: | |
2 | chr4:3720745..3724824-chr4:3727644..3730429,3 | K562 | blood: | |
3 | chr4:3720840..3724300-chr4:3724381..3726602,3 | MCF-7 | breast: | |
4 | chr4:3719651..3722174-chr4:3722524..3724517,2 | K562 | blood: | |
5 | chr4:3715270..3718190-chr4:3721526..3723393,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2748770 | chr4:3721251-3721252 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs7377501 | chr4:3721269-3721270 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs114744869 | chr4:3721286-3721287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs7375509 | chr4:3721299-3721300 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs558871529 | chr4:3721300-3721301 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139550823 | chr4:3721314-3721315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74971822 | chr4:3721339-3721340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568204069 | chr4:3721355-3721356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149303463 | chr4:3721403-3721404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375909213 | chr4:3721408-3721409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545038146 | chr4:3721409-3721410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs560330454 | chr4:3721419-3721420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74456571 | chr4:3721437-3721438 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs546115043 | chr4:3721453-3721454 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs185633377 | chr4:3721459-3721460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58187538 | chr4:3721460-3721461 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190493349 | chr4:3721499-3721500 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs386670773 | chr4:3721511-3721512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2748769 | chr4:3721521-3721522 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs200875520 | chr4:3721527-3721528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75851937 | chr4:3721584-3721585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527802259 | chr4:3721585-3721586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116010143 | chr4:3721605-3721606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs547833848 | chr4:3721613-3721614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566703436 | chr4:3721618-3721619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538835648 | chr4:3721633-3721634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Retinitis pigmentosa | 18421352 | CNVD |
Wolf-Hirschhorn syndrome | 19259404 | CNVD |
Bladder cancer | 19242612 | CNVD |
Breast cancer | 19242612 | CNVD |
Congenital anomalies of the kidney and urinary tract | 19242612 | CNVD |
abnormal development | 18461090 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Wilms tumour | 21544195 | CNVD |
Melanoma | 20688739 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Lung cancer | 18438408 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:3717600-3722400 | Weak transcription | Fetal Kidney | kidney |
2 | chr4:3720400-3722800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr4:3721400-3722400 | Weak transcription | H9 Cell Line | embryonic stem cell |